March 14, 2022
Life Sciences
  • Pfizer CEO Albert Bourla said on Sunday that a fourth dose of the COVID-19 vaccine will be necessary to continue to help keep hospitalizations manageable and sicknesses milder. He said Pfizer plans to submit data for a fourth COVID-19 dose, and then see what non-Pfizer experts say.” He also reiterated Pfizer’s goal of creating a vaccine effective against all variants of COVID-19 for longer periods of time. (Articles here, here, here, here, and here)